
Vildaspec 100mg Tablet SR
Marketer
Spectra Therapeutics Pvt Ltd
Salt Composition
Vildagliptin (100mg)
Overview Vildaspec 100mg Tablet SR
Glycemia Control 100mg Extended-Release Tablets are indicated for the management of type 2 diabetes. This medication works in conjunction with a balanced diet and regular physical activity to regulate blood glucose, thereby mitigating the risk of severe diabetic complications such as nephropathy and visual impairment. Prescribing typically occurs when dietary and exercise modifications, or other therapies, prove inadequate in achieving glycemic control. It may be administered alone or as part of a combination regimen with other antidiabetic agents. Administration is independent of food intake. Dosage is individualized based on the patient's clinical status and blood sugar readings. Strict adherence to the physician's prescribed regimen is crucial. Consistent daily dosing at the same time maximizes therapeutic efficacy. Discontinuation should only occur under medical supervision. Continued adherence to the recommended dietary and exercise plan is paramount. Lifestyle choices significantly influence diabetes management. Commonly reported adverse effects include hypoglycemia, tremors, cephalalgia, vertigo, lassitude, and nausea. Recognizing hypoglycemic symptoms (lightheadedness, diaphoresis, dizziness, syncope, xerostomia) and implementing appropriate countermeasures (e.g., glucose tablets) is vital. Persistent or concerning side effects warrant medical consultation. Prior to initiating therapy, patients should disclose any history of renal, cardiovascular, or pancreatic disease. Pregnant or lactating individuals require medical guidance. Potential drug interactions necessitate complete disclosure of all concurrently used medications to the prescribing physician. Alcohol consumption should be minimized due to the heightened risk of hypoglycemia. Regular monitoring of renal function and blood glucose levels is typically necessary to assess therapeutic efficacy.
Primary Ingredients of Vildaspec 100mg Tablet SR
No text provided to rephrase.
Uses of Vildaspec 100mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vildaspec 100mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildaspec 100mg Sustained-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Vildaspec 100mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Vildaspec 100mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vildaspec 100mg Tablet SR whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Vildaspec 100mg Tablet SR works:
Vildaspec 100mg sustained-release tablets are used to manage diabetes. Their mechanism involves stimulating insulin secretion from the pancreas while simultaneously suppressing hyperglycemic hormones. This dual action leads to lower blood glucose, both before and after meals.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vildaspec 100mg Tablet SR is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vildaspec 100mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vildaspec 100mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Vildaspec 100mg sustained-release tablet can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The extended-release Vildaspec 100mg tablet is generally safe for individuals with kidney impairment, and typically doesn't require a dosage change. Nevertheless, patients exhibiting moderate to severe kidney disease may need adjusted dosing. Physician consultation is advised.
LiverUNSAFE
Patients with liver impairment should likely avoid Vildaspec 100mg SR tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Vildaspec 100mg Tablet SR :
Should you forget a Vildaspec 100mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vildaspec 100mg Tablet SR
| Label | Value |
|---|---|
| Chemical Classification | Pyrrolidinecarbonitrile |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Behavioral Class | Dipeptidyl peptidase-4 inhibitors |
